Kiromic BioPharma Inc (KRBP)
3.11
+0.03
(+0.97%)
USD |
OTCM |
May 17, 13:42
Kiromic BioPharma Total Assets (Quarterly): 12.63M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.63M |
| December 31, 2023 | 12.17M |
| September 30, 2023 | 14.23M |
| June 30, 2023 | 13.64M |
| March 31, 2023 | 13.11M |
| December 31, 2022 | 11.97M |
| September 30, 2022 | 13.02M |
| June 30, 2022 | 19.52M |
| March 31, 2022 | 25.89M |
| Date | Value |
|---|---|
| December 31, 2021 | 30.73M |
| September 30, 2021 | 38.96M |
| June 30, 2021 | 6.439M |
| March 31, 2021 | 10.15M |
| December 31, 2020 | 12.83M |
| September 30, 2020 | 3.180M |
| June 30, 2020 | 3.882M |
| March 31, 2020 | 4.469M |
| December 31, 2019 | 2.653M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.653M
Minimum
Dec 2019
38.96M
Maximum
Sep 2021
13.86M
Average
12.73M
Median
Total Assets (Quarterly) Benchmarks
| Lisata Therapeutics Inc | 48.24M |
| Achieve Life Sciences Inc | 70.03M |
| Syra Health Corp | 4.552M |
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 19.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.84M |
| Shareholders Equity (Quarterly) | -7.212M |